Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Ketamine, Amitriptyline, and Lidocaine for Pruritus
NCT03096444Phase 2Terminated
- Start
- May 2017
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ketamine transdermal patch, amitriptyline, lidocaine 10% oropharyngeal spray in pruritus. Started May 2017; status: terminated.
02
Drugs
ketamine transdermal patchamitriptylinelidocaine 10% oropharyngeal spray
03
Conditions
pruritus
Beyond the preview
Go deeper on NCT03096444.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03096444.